Zhejiang University

This early-phase study tested a new CAR-T cell therapy called ThisCART19A in 10 adults with relapsed or hard-to-treat B-cell leukemia. The goal was to check safety and see how well the treatment worked. Participants received a single infusion of their own engineered immune cells,…

This study tested whether adding an immunotherapy drug (anti-PD-1 antibody) to standard chemotherapy can help people with locally advanced or borderline resectable pancreatic cancer. About 392 participants were randomly assigned to receive either chemo alone or chemo plus the imm…

This study tested whether a low dose of the drug chidamide, given after a donor stem cell transplant, can help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. Forty-four patients aged 14 to 70 who were at high risk of relapse took part. The main g…

This early-phase study tested whether combining donafinib with an anti-PD-1 antibody can safely reduce the chance of liver cancer returning after surgery. It included 30 patients with high-risk features like microvascular invasion or multiple tumors. The main goal was to see how …

This study tested a new device called the COMBO Endoscopy Oropharyngeal Airway in 104 adults undergoing a lung scope procedure under sedation. The device combines oxygen support, breathing monitoring, and a bite block to prevent low oxygen levels. The goal was to see if it reduce…

This study looked at whether a high-flow nasal cannula (a device that delivers warm, moist oxygen through the nose) can prevent low oxygen levels during sedated gastrointestinal endoscopy in people at high risk for obstructive sleep apnea. The trial included 80 adults with a STOP…

This study looked at whether using 3D reconstructed images of the pelvis can help doctors perform more precise prostate biopsies. A total of 436 men with suspicious prostate lesions took part. Before biopsy, doctors used special software to create a 3D model to plan where to take…